Researchers indicate that the Lumipulse p-tau217 assay may reduce over 50% of lumbar punctures performed for diagnosing ...

Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...

Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time. Those medications, however, are not without their risks and side effects.

A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving early Alzheimer’s diagnosis. Unlike amyloid-beta, tau neurofibrillary ...

Unlike other prior studies that detected changes in AD markers following COVID-19 infection ( Jan 2021 news; May 2023 conference news ), first author Duff and colleagues had baseline data on every ...

Tampa’s Empath Health Suncoast Hospice staff members received hands-on training to help them better understand what it feels ...

Alzheimer's patients with a baseline CDR-SB score of 3.5 could expect approximately 4 additional months (95% CI 2-7 months) ...

Researchers have developed a novel analytical method for tracking disease progression in patients that shows great potential ...

Researchers have developed a novel analytical method for tracking disease progression in patients that shows great potential for healthcare implementation.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

BOSTON, MA / ACCESS Newswire / February 13, 2025 / Medisafe, the leading digital health and patient engagement platform, is proud to announce the launch of PATHWAYS, a new, complimentary tool designed ...